Vaccines Archives

News and Trends 20 Jul 2022

IVI and Moderna sign MOU for vaccine R&D

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Moderna, a biotech company working on messenger RNA (mRNA) therapeutics and vaccines, have signed a Memorandum of Understanding (MOU) to partner on collaborative vaccine research and development. “IVI welcomes this […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

SINOVAC starts influenza vaccine trial in Chile

Sinovac Biotech Ltd., a provider of biopharmaceutical products in China, has initiated a phase III clinical trial for SINOVAC’s inactivated quadrivalent influenza vaccine in Chile through a collaboration with the Pontificia Universidad Católica de Chile. SINOVAC said the results aim to provide scientific evidence to support its influenza vaccine immunogenicity and protection capacity. This clinical […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

South Korean company SK Bioscience has extended its partnership with Novavax, Inc., a U.S. biotechnology company specializing in next-generation vaccines, for the manufacturing and supply of Novavax COVID-19 vaccine targeting Omicron variants in prefilled syringes. SK Bioscience and Novavax signed an agreement for the technology transfer of Novavax proprietary COVID-19 variant antigen materials and manufacturing […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 15 Jul 2022

WHO and UNICEF sound the alarm as global vaccination coverage continues to decline

Amid worldwide disruptions caused by the COVID-19 pandemic, WHO and UNICEF report the largest continued backslide in childhood vaccinations in approximately three decades, with 25 million infants missing out on lifesaving vaccines in 2021 alone. It was hoped that the cohort of children that missed their vaccinations in 2020 would be caught up in 2021, […]

July 15, 2022 - 4 minutesmins - By Omnia Ibrahim

covid-19 vaccine emergency use authorization

News and Trends 14 Jul 2022

FDA authorizes the first protein-based COVID-19 vaccine in the US

Novavax, Inc. has been given emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) for its adjuvanted, protein-based COVID-19 shot. Branded Nuvaxovid and Covovax outside the U.S., Novavax’s vaccine is already approved for use in several countries worldwide, including the EU, U.K., Canada, Australia, South Korea and India. During public health emergencies, […]

July 14, 2022 - 2 minutesmins - By Omnia Ibrahim

News and Trends 7 Jul 2022

Vaccizone chooses partner to fast-track development of COVID-19 vaccine

A vaccine development company has chosen a partner to fast-track the development of its SARS-CoV-2 product for European clinical trials. Vaccizone has chosen viral vector contract development and manufacturing company (CDMO) antigen delivery technology Exothera S.A to accelerate the vaccine. Vaccizone is the inventor of the ASC Technology, a first-in-class antigen delivery platform for generating […]

July 7, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

Companies come together in fight against Dengue Fever

A vaccine to treat dengue fever, the mosquito-borne disease, is the end goal of two companies who have signed an agreement to produce and commercialize a lead candidate in the fight against the disease. Emergex Vaccines Holding Limited, a clinical-stage biotech company, recently announced that it has agreed a collaboration with the Molecular Biology Institute […]

July 1, 2022 - 4 minutesmins - By Liza Laws

News and Trends 29 Jun 2022

Encouraging results from respiratory diseases vaccine trial

A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with life threatening respiratory diseases. Icosavax says that in an interim phase 1/1b trial its vaccine IVX-121 has demonstrated robust immunological response to respiratory syncytial virus (RSV) in both young and older adult groups. The vaccine was generally tolerated with no […]

June 29, 2022 - 4 minutesmins - By Liza Laws

News and Trends 27 Jun 2022

Saudi Arabia to inject $3B into vaccines and medicines industry

Saudi Arabia is boosting biotech and looking to become a center for the vaccine industry. The Saudi Arabian Minister of Industry and Mineral Resources, chairman of the manufacturing vaccines and vital medicines committee, Bandar bin Ibrahim Alkhorayef, has announced the launch of several investment opportunities in the vaccines and vital medicines industry, valued at $3.4 […]

June 27, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 27 Jun 2022

Covid vaccine granted marketing authorization in Europe

Specialty vaccine company, Valneva, has been given marketing authorization in Europe for its inactivated whole-virus COVID-19 vaccine VLA2001. This is a turnaround from the company’s situation in May of this year when the stock price was knocked down by 20% when gaining traction in the EU was proving to be a struggle. Despite authorization from […]

June 27, 2022 - 3 minutesmins - By Liza Laws

News and Trends 24 Jun 2022

Study reveals progress for those with hepatitis B

A clinical-stage biopharma company has announced its study of product VTP-300 for use in patients with hepatitis B has resulted in positive safety and efficacy data. Vaccitech plc deals with novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases, cancer, and autoimmune diseases. The updated analysis includes 39 patients with at least […]

June 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 24 Jun 2022

Covid and malaria vaccines on track for mass production in Rwanda

Construction of the first African messenger RNA (mRNA) manufacturing facility has started in Africa. This means Biopharmaceutical New Technologies (BioNTech) SE is a step closer to producing mRNA vaccines that teach human cells how to make a protein that will trigger an immune response inside the body. The company is a next generation immunotherapy company […]

June 24, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Vaccines

IVI and Moderna sign MOU for vaccine R&D

SINOVAC starts influenza vaccine trial in Chile

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

WHO and UNICEF sound the alarm as global vaccination coverage continues to decline

FDA authorizes the first protein-based COVID-19 vaccine in the US

Vaccizone chooses partner to fast-track development of COVID-19 vaccine

Companies come together in fight against Dengue Fever

Encouraging results from respiratory diseases vaccine trial

Saudi Arabia to inject $3B into vaccines and medicines industry

Covid vaccine granted marketing authorization in Europe

Study reveals progress for those with hepatitis B

Covid and malaria vaccines on track for mass production in Rwanda

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!